AMNEAL PHARMACEUTICALS INC's ticker is AMRX and the CUSIP is 03168L105. A total of 135 filers reported holding AMNEAL PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 0.68 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $130,904 | +11.7% | 31,020 | -63.2% | 0.00% | – |
Q1 2023 | $117,188 | +155.4% | 84,308 | +265.7% | 0.00% | – |
Q4 2022 | $45,883 | -73.9% | 23,057 | -58.3% | 0.00% | -100.0% |
Q2 2022 | $176,000 | -53.4% | 55,303 | -39.0% | 0.00% | -50.0% |
Q1 2022 | $378,000 | +51.2% | 90,608 | +73.3% | 0.00% | +100.0% |
Q4 2021 | $250,000 | -15.3% | 52,287 | -5.5% | 0.00% | 0.0% |
Q3 2021 | $295,000 | -22.8% | 55,326 | -25.8% | 0.00% | 0.0% |
Q2 2021 | $382,000 | -10.1% | 74,599 | -19.8% | 0.00% | -66.7% |
Q4 2020 | $425,000 | -33.1% | 93,034 | -43.2% | 0.00% | -66.7% |
Q3 2020 | $635,000 | +1033.9% | 163,757 | +1296.1% | 0.01% | +800.0% |
Q2 2020 | $56,000 | -58.2% | 11,730 | -69.5% | 0.00% | -66.7% |
Q1 2020 | $134,000 | -93.1% | 38,437 | -90.5% | 0.00% | -75.0% |
Q4 2019 | $1,942,000 | +63.3% | 402,908 | -1.7% | 0.01% | +9.1% |
Q3 2019 | $1,189,000 | -70.7% | 410,003 | +43.0% | 0.01% | -74.4% |
Q1 2019 | $4,064,000 | +325.5% | 286,808 | +306.5% | 0.04% | +290.9% |
Q4 2018 | $955,000 | – | 70,557 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Fosun International Ltd | 21,521,301 | $90,819,890 | 14.58% |
Eversept Partners, LP | 2,644,988 | $11,161,849 | 0.94% |
TPG GP A, LLC | 12,328,767 | $52,027,397 | 0.90% |
Nantahala Capital Management | 2,212,757 | $9,337,835 | 0.80% |
Rubric Capital Management LP | 4,024,500 | $16,983,390 | 0.64% |
Hedges Asset Management LLC | 84,600 | $357,012 | 0.31% |
Signature Wealth Management Partners, LLC | 66,666 | $281,331 | 0.28% |
Tejara Capital Ltd | 96,672 | $407,956 | 0.23% |
Tranquilli Financial Advisor LLC | 71,414 | $301,367 | 0.22% |
EAM Investors, LLC | 230,271 | $971,744 | 0.19% |